rs104893632
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_080916.3(DGUOK):c.679G>A(p.Glu227Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_080916.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251342Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135846
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727196
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Published functional studies demonstrate a severely decreased catalytic rate (PMID: 14623087); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 27324545, 18825706, 17892433, 22494545, 24478274, 28493820, 29137425, 30366773, 12205643, 35488641, 19103789, 32482602, 14623087) -
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 227 of the DGUOK protein (p.Glu227Lys). This variant is present in population databases (rs104893632, gnomAD 0.01%). This missense change has been observed in individual(s) with mitochondrial DNA depletion syndrome (PMID: 12205643, 19103789, 27324545, 28493820, 32482602). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8158). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DGUOK protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.679G>A (p.E227K) alteration is located in exon 5 (coding exon 5) of the DGUOK gene. This alteration results from a G to A substitution at nucleotide position 679, causing the glutamic acid (E) at amino acid position 227 to be replaced by a lysine (K). Based on data from gnomAD, the A allele has an overall frequency of <0.01% (6/251342) total alleles studied. This alteration has been reported in the homozygous state or compound heterozygous with a second pathogenic DGUOK variant in trans in patients with mitochondrial DNA depletion syndrome (Deng, 2016; Lee, 2009; Salviati, 2002; Xia, 2020). Experimental studies with recombinant E227K enzyme showed a severely decreased catalytic rate (Wang, 2003). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
DGUOK-related disorder Pathogenic:1
Variant summary: DGUOK c.679G>A (p.Glu227Lys) results in a conservative amino acid change located in the Deoxynucleoside kinase domain (IPR031314) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251342 control chromosomes (gnomAD). c.679G>A has been reported in the literature in multiple individuals affected with DGUOK-Related Disorders (examples: Salviati_2002,Lee_2009, Deng_2016,Unal_2017, Xia_2020). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 27324545, 12205643, 32482602, 19103789, 28493820). ClinVar contains an entry for this variant (Variation ID: 8158). Based on the evidence outlined above, the variant was classified as pathogenic. -
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4;C5191055:Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);CN305369:Portal hypertension, noncirrhotic, 1 Pathogenic:1
PM2_Supporting+PP3_Strong+PM3_VeryStrong+PP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at